It's Monday, November 23rd.

Welcome to Market Foolery.

I'm Chris Hill with me today.

It's Jason Moser.

Thanks for being here.

Thank you for having me.

We're going to talk social media stocks.

We are going to dip in the full mail bag, but for the third Monday in a row we get promising

news on vaccines, AstraZeneca's trials showing a good range of efficacy.

We have Regeneron Pharmaceutical getting emergency use approval from the FDA.

Pfizer's vaccine could get approval in the UK this week. Here in the

states the FDA is scheduled to meet on December 10th to consider approval for five

its vaccine. So more good news all of that brings us to corn ferry

shares of the global consulting firm up this morning after second quarter profits and revenue came in higher than expected.

This is one of those businesses, Jason, that you look back to late March when pretty much every stock or most stocks were falling off a shelf.

You could be forgiven for looking at a consulting business like Corn Ferry and thinking, boy, they're in real trouble.

This isn't just the broad market sell-off.

They are in real trouble and they have bounced back pretty nicely.

Yeah, they have, you know, and I mean,

Corn Ferry is a small company.

When you look at the consulting gig,

I mean, that's what Corn Ferry ultimately is,

...